search
Back to results

Evaluation of the F&P Caramel Nasal Mask, US, 2023

Primary Purpose

Obstructive Sleep Apnea

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
F&P Caramel
Sponsored by
Fisher and Paykel Healthcare
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obstructive Sleep Apnea

Eligibility Criteria

22 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Persons who are ≥22 years of age Persons who weigh ≥66 pounds Persons who have been prescribed PAP therapy by a physician Persons who are existing nasal mask or sub-nasal mask users with ≥3 months of use prior to enrolment in the clinical trial Persons who are compliant with PAP therapy for ≥4 hours per night for ≥70% of nights for a 14-day period within 30 days prior to enrolment in the clinical trial Persons who are fluent in spoken and written English Persons who possess the capacity to provide informed consent Exclusion Criteria: Persons who are intolerant to PAP therapy Persons who possess, or suffer from, anatomical or physiological conditions which make PAP therapy inappropriate Persons who are required to use PAP therapy for >12 hours per day or for extensive periods, not including sleep or naps Persons who are trying to get pregnant, are pregnant, or think they may be pregnant Persons who have an IPAP pressure of >30 cmH2O if on BPAP Persons who use a PAP therapy device for the delivery of medicines, except supplemental oxygen Persons who use a PAP therapy device that does not possess data recording capabilities to capture AHI and a numerical indicator of leak that is accessible to the investigation site

Sites / Locations

    Outcomes

    Primary Outcome Measures

    Apnea-Hypopnea Index
    Acceptable maintenance or lower (improved score) from baseline. Scores below 5 indicate a better outcome.
    Epworth Sleepiness Scale
    Acceptable maintenance or lower (improved score) from baseline. Scores below 11 indicate a better outcome.

    Secondary Outcome Measures

    Full Information

    First Posted
    September 24, 2023
    Last Updated
    September 24, 2023
    Sponsor
    Fisher and Paykel Healthcare
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT06060717
    Brief Title
    Evaluation of the F&P Caramel Nasal Mask, US, 2023
    Official Title
    Evaluation of the F&P Caramel Nasal Mask, US, 2023
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    November 27, 2023 (Anticipated)
    Primary Completion Date
    December 11, 2023 (Anticipated)
    Study Completion Date
    June 11, 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Fisher and Paykel Healthcare

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    Yes
    Device Product Not Approved or Cleared by U.S. FDA
    Yes
    Product Manufactured in and Exported from the U.S.
    No

    5. Study Description

    Brief Summary
    The purpose of this clinical investigation is to evaluate the performance and safety of the F&P Caramel nasal mask in a home environment.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Obstructive Sleep Apnea

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    45 (Anticipated)

    8. Arms, Groups, and Interventions

    Intervention Type
    Device
    Intervention Name(s)
    F&P Caramel
    Intervention Description
    Nasal mask
    Primary Outcome Measure Information:
    Title
    Apnea-Hypopnea Index
    Description
    Acceptable maintenance or lower (improved score) from baseline. Scores below 5 indicate a better outcome.
    Time Frame
    14±5 days
    Title
    Epworth Sleepiness Scale
    Description
    Acceptable maintenance or lower (improved score) from baseline. Scores below 11 indicate a better outcome.
    Time Frame
    14±5 days

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    22 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Persons who are ≥22 years of age Persons who weigh ≥66 pounds Persons who have been prescribed PAP therapy by a physician Persons who are existing nasal mask or sub-nasal mask users with ≥3 months of use prior to enrolment in the clinical trial Persons who are compliant with PAP therapy for ≥4 hours per night for ≥70% of nights for a 14-day period within 30 days prior to enrolment in the clinical trial Persons who are fluent in spoken and written English Persons who possess the capacity to provide informed consent Exclusion Criteria: Persons who are intolerant to PAP therapy Persons who possess, or suffer from, anatomical or physiological conditions which make PAP therapy inappropriate Persons who are required to use PAP therapy for >12 hours per day or for extensive periods, not including sleep or naps Persons who are trying to get pregnant, are pregnant, or think they may be pregnant Persons who have an IPAP pressure of >30 cmH2O if on BPAP Persons who use a PAP therapy device for the delivery of medicines, except supplemental oxygen Persons who use a PAP therapy device that does not possess data recording capabilities to capture AHI and a numerical indicator of leak that is accessible to the investigation site

    12. IPD Sharing Statement

    Learn more about this trial

    Evaluation of the F&P Caramel Nasal Mask, US, 2023

    We'll reach out to this number within 24 hrs